Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XENE | CRSP | ERAS | ||
| Company | Xenon Pharmaceuticals Inc | Crispr Therapeutics Ag | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 61.30 | 52.12 | 15.40 | ||
| High | 61.38 | 52.12 | 15.77 | ||
| Low | 58.75 | 49.85 | 15.22 | ||
| Latest | 59.04 | 49.93 | 15.50 | ||
| Change | -1.57 | -2.87 | -0.08 | ||
| % Change | -2.59% | -5.44% | -0.51% | ||
| Volume | 5,547,000 | 6,326,400 | 4,768,600 | ||
| 20-Day Average Volume | 1,861,105 | 2,189,795 | 3,931,745 | ||
| Previous Close | 60.61 | 52.80 | 15.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.57 | 55.36 | 13.74 | ||
| 20-Day Raw Stochastic | 78.85% | 22.58% | 81.90% | ||
| 20-Day Relative Strength | 70.83 | 43.58 | 76.58 | ||
| Weighted Alpha | +54.81 | +8.66 | +699.20 | ||
| Today's Opinion | 100% Buy | 64% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +37.14% since 03/04/26 | -16.78% since 03/04/26 | +2.51% since 03/04/26 | ||
| Low | 41.05 on 03/06/26 | 49.85 on 03/11/26 | 14.74 on 03/05/26 | ||
| High | 63.95 on 03/10/26 | 59.82 on 03/05/26 | 16.41 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +38.07% since 02/11/26 | +3.33% since 02/11/26 | +34.08% since 02/11/26 | ||
| Low | 40.86 on 02/17/26 | 47.39 on 02/12/26 | 11.65 on 02/12/26 | ||
| High | 63.95 on 03/10/26 | 61.76 on 02/26/26 | 16.41 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +35.23% since 12/11/25 | -14.05% since 12/11/25 | +358.58% since 12/11/25 | ||
| Low | 39.29 on 01/20/26 | 45.53 on 02/05/26 | 3.32 on 12/23/25 | ||
| High | 63.95 on 03/10/26 | 61.76 on 02/26/26 | 16.41 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +58.62% since 09/11/25 | -10.66% since 09/11/25 | +862.73% since 09/11/25 | ||
| Low | 35.60 on 09/15/25 | 45.53 on 02/05/26 | 1.53 on 09/15/25 | ||
| High | 63.95 on 03/10/26 | 78.48 on 10/08/25 | 16.41 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,042,146 | 5,068,008 | 4,823,366 | ||
| Shares Outstanding, K | 83,190 | 95,985 | 309,587 | ||
| Annual Sales | 7,500,000 | 3,510,000 | 0 | ||
| Annual Net Income | -345,910,000 | -581,600,000 | -161,650,000 | ||
| Last Quarter Sales | 0 | 860,000 | 0 | ||
| Last Quarter Net Income | -105,260,000 | -130,610,000 | -30,610,000 | ||
| 60-Month Beta | 0.91 | 1.72 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.31 on 02/26/26 | -1.37 on 02/12/26 | -0.11 on 11/12/25 | ||
| Latest Earnings Date | 05/11/26 | 05/05/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||